The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zirtek Allergy Relief 10 mg film-coated tablets

UCB (Pharma) Ireland LimitedPA0891/008/005

Main Information

Trade NameZirtek Allergy Relief 10 mg film-coated tablets
Active SubstancesCetirizine dihydrochloride
Dosage FormFilm-coated tablet
Licence HolderUCB (Pharma) Ireland Limited
Licence NumberPA0891/008/005

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine


License statusAuthorised
Licence Issued27/03/2015
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceSupply through pharmacies only and promotion to the public subject to the following restrictions: maximum strength of 10 mg, maximum daily dose of 10 mg and maximum pack size of 30 tablets 30 tablets. As a prescription only item in pack sizes exceeding 30 tablets. Promotion: To the professions for pack sizes exceeding 30 tablets.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back